00:00US President Donald Trump has given generic drug makers two years to move production to the United States or face
00:06tariffs of up to 200%.
00:08The move is part of his push to bring pharmaceutical manufacturing back to the US but could disrupt global supply
00:15chains for low-cost medicines.
00:19Under the plan, generic medicines imported into the US will remain tariff-free until August 2028.
00:25After that, they will face a 100% import duty, rising to 200% a year later, for companies that
00:32fail to shift productions to the United States.
00:35Generic medicines account for the vast majority of prescriptions filled in the US, with many produced in India, China and
00:43Europe through complex global supply chains.
00:45Trade analysts say the plan could encourage more domestic manufacturing but warn that building pharmaceutical plants in the US is
00:53costly and time-consuming, while many of the raw materials would still need to be imported.
00:59The stakes are especially high for India, which supplies nearly half of all generic medicines used in the United States.
01:05The code ofุญ anatomical comes in some of its'
Comments